Search
Download Navigator Brochure

Welcome to Applied Physiology

Targeted Guidance for Critical Care

Applied Physiology specializes in the development of targeted guidance devices for use in critical care. These devices use conventional, monitored data to generate clinical decision support. They implement a self-adaptive protocol that continually guides clinicians in making treatment decisions for their patients. These guidance devices have the potential to improve patient outcomes, by enhancing teamwork and unifying goals in critical care units.

Applied Physiology’s flagship product Navigator™, which targets pressure and flow in the circulatory system, will be available for sale in Europe and Australia in the second quarter 2010. It will be available for sale in the US pending regulatory approval from the FDA.

PRESS RELEASE (12 April 2010)
TGA APPROVAL AND CE MARK GRANTED - NAVIGATOR™ IS APPROVED FOR SALE IN AUSTRALIA AND EUROPE

Navigator™, the breakthrough cardiovascular care system from Applied Physiology, has received TGA certification and CE marking and is now approved for sale in Australia and Europe. This new device, with its unique graphical display will be available throughout these territories from second quarter, 2010... more

PRESS RELEASE (5 February 2010)
DAFFAS TO NAVIGATE APPLIED PHYSIOLOGY'S FUTURE

Applied Physiology - developers of the breakthrough cardiovascular care system Navigator™ - has appointed Philip Daffas as its new chief executive. Specialising in the development of targeted guidance devices for use in critical care, Applied Physiology found Daffas after a six-month international search for a CEO with the blue chip experience to guide the company’s Navigator™ flagship product to market this year... more